Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tribendimidine for treatment of Opisthorchis viverrini infection in Laos
ISRCTN96948551Phase 2Completed
- Sponsor
- Swiss Tropical and Public Health Institute
- Start
- Oct 2012
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of tribendimidine and praziquantel in opisthorchiasis (8 arms), sponsored by Swiss Tropical and Public Health Institute. Primary endpoints: Cure rate for Opisthorchis viverrini infection and Egg reduction rate for Opisthorchis viverrini infection. Started Oct 2012; status: completed.
02
Drugs
tribendimidinepraziquantel
03
Conditions
opisthorchiasis
Beyond the preview
Go deeper on ISRCTN96948551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN96948551.